Sakamoto Noriko, Maeda Shoichi, Ikeda Noriaki, Ishibashi Hiromi, Nobutomo Koichi
Department of Health Services, Management and Policy, Kyushu University Graduate School of Medicine, Fukuoka 812-8582, Japan.
Med Sci Law. 2002 Jul;42(3):200-6. doi: 10.1177/002580240204200304.
In medical malpractice litigation, the cooperation of medical experts is important. However, the appointment of experts has become problematic in Japan, apparently because many medical experts refuse to act in this capacity. However, this supposition has not until now been supported by quantitative evidence, since the fact that so few judgments in Japan are published made it impossible to investigate the situation. Therefore, we aim to show the state of the use of experts in medical malpractice litigation using objective data. Over the last ten years, the rate of the use of experts has averaged only 22.5%, varying according to region. Experts were used in 24.5% of cases involving an attorney on the patient's side, and in only 3.4% of cases where no attorney was used. The success rate of patients was higher when experts were adopted (39.1%) than when they were not (29.9%). The length of litigation involving experts was 4.0 years, and 2.7 years when no expert was involved. This research suggested the necessity of establishing a formal cooperation system as soon as possible in Japan with no regional maldistribution.
在医疗事故诉讼中,医学专家的合作至关重要。然而,在日本,专家的指定已成为一个问题,显然是因为许多医学专家拒绝担任这一角色。然而,到目前为止,这一假设尚未得到定量证据的支持,因为日本公布的判决极少,使得调查这种情况变得不可能。因此,我们旨在利用客观数据展示医疗事故诉讼中专家的使用状况。在过去十年中,专家的使用率平均仅为22.5%,因地区而异。在患者方有律师参与的案件中,专家的使用率为24.5%,而在没有律师参与的案件中,这一比例仅为3.4%。采用专家时患者的成功率(39.1%)高于未采用专家时(29.9%)。涉及专家的诉讼时长为4.0年,不涉及专家时为2.7年。这项研究表明,日本有必要尽快建立一个不存在地区分布不均的正式合作体系。